Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease-Reference-Cited by-同舟云学术

Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease

Published:2024-03 Issue:9 Volume:83 Page:873-886
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Berman Adam N.,Biery David W.,Besser Stephanie A.,Singh Avinainder,Shiyovich Arthur^ORCID,Weber Brittany N.,Huck Daniel M.^ORCID,Divakaran Sanjay^ORCID,Hainer Jon,Kaur Gurleen,Blaha Michael J.,Cannon Christopher P.,Plutzky Jorge,Januzzi James L.,Booth John N.,López J. Antonio G.,Kent Shia T.,Nasir Khurram,Di Carli Marcelo F.,Bhatt Deepak L.^ORCID,Blankstein Ron

Funder

Amgen Inc

Publisher

Elsevier BV

Reference48 articles.

1. for the Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;Erqou;JAMA,2009

2. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study;Kamstrup;Circulation,2008

3. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction;Kamstrup;JAMA,2009

4. Genetic associations with valvular calcification and aortic stenosis;Thanassoulis;N Engl J Med,2013

5. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population;Kamstrup;J Am Coll Cardiol,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipoprotein(a) Levels in Severe Aortic Stenosis Referred for Transcatheter Aortic Valve Implantation Compared to Controls;JACC: Advances;2024-10

2. Lipoprotein (a) and lipid-lowering treatment from the perspective of a cardiac surgeon. An impact on the prognosis in patients with aortic valve replacement and after heart transplantation;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-09

3. Effectiveness of cascade screening for elevated lipoprotein(a), an underdiagnosed family disorder;Current Opinion in Lipidology;2024-08-27

4. Lipoprotein(a) in interventional cardiology: identifying patients at highest risk of recurrent cardiovascular events through early recognition – a case based review;Expert Review of Cardiovascular Therapy;2024-08-02

5. MANAGING LIPID LEVELS IN THE LIFE-LONG REHABILITATION OF PATIENTS WITH CORONARY ARTERY DISEASE;Kinesiologia Slovenica scientific journal on sport;2024-07-29